BerGenBio ASA: Invitation to third quarter 2023 results webcast
Bergen, Norway, 6 November 2023 - BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, will announce its results for the third quarter 2023 on Tuesday 14 November 2023. BerGenBio's senior management team will provide a business update at 10:00 am CET. The presentation will webcast live. To participate in the webcast please use the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20231114_1/ A recording of the webcast will be available at www.bergenbio.com in the